ESTRO38 Congress Report

Figure 1: Kaplan-Meier biochemical progression-free survival curves for all patients treated with single dose HDR monotherapy (left) and comparing low-, intermediate- and high-risk patients (right). bPFS, biochemical progression-free survival

Congress report | BRACHYTHERAPY

27